Header Logo

Connection

David Moore to HIV Infections

Back to Details
This is a "connection" page, showing publications David Moore has written about HIV Infections.
David Moore
Connection Strength
6,278
HIV Infections
  1. A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men. AIDS Behav. 2022 Jan; 26(1):196-203.
    View in: PubMed
    Score: 0,215
  2. The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders. AIDS. 2021 03 01; 35(3):429-437.
    View in: PubMed
    Score: 0,209
  3. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study. Arch Clin Neuropsychol. 2021 Feb 12; 36(2):151-164.
    View in: PubMed
    Score: 0,208
  4. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 02; 27(1):160-167.
    View in: PubMed
    Score: 0,207
  5. Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):522-526.
    View in: PubMed
    Score: 0,201
  6. Cumulative Burden of Depression and Neurocognitive Decline Among Persons With HIV: A Longitudinal Study. J Acquir Immune Defic Syndr. 2020 07 01; 84(3):304-312.
    View in: PubMed
    Score: 0,200
  7. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging. AIDS Res Hum Retroviruses. 2019 Nov/Dec; 35(11-12):985-998.
    View in: PubMed
    Score: 0,189
  8. Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):15-23.
    View in: PubMed
    Score: 0,180
  9. Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults. Behav Med. 2019 Jul-Sep; 45(3):210-220.
    View in: PubMed
    Score: 0,178
  10. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis. 2018 05 02; 66(10):1566-1572.
    View in: PubMed
    Score: 0,172
  11. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res. 2017 Aug; 41(8):1518-1525.
    View in: PubMed
    Score: 0,162
  12. Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):243-249.
    View in: PubMed
    Score: 0,158
  13. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015 Mar; 19(3):459-71.
    View in: PubMed
    Score: 0,138
  14. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 Jan 28; 29(3):323-30.
    View in: PubMed
    Score: 0,137
  15. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012; 7(11):e47310.
    View in: PubMed
    Score: 0,118
  16. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66.
    View in: PubMed
    Score: 0,117
  17. Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel? J Acquir Immune Defic Syndr. 2012 Aug 15; 60(5):503-10.
    View in: PubMed
    Score: 0,116
  18. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012; 24(12):1504-13.
    View in: PubMed
    Score: 0,113
  19. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 Feb; 17(1):50-7.
    View in: PubMed
    Score: 0,103
  20. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006 Apr 04; 20(6):879-87.
    View in: PubMed
    Score: 0,074
  21. Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):454-461.
    View in: PubMed
    Score: 0,056
  22. Sexually transmitted infections among participants in an HIV PrEP adherence trial. Int J STD AIDS. 2022 03; 33(4):397-403.
    View in: PubMed
    Score: 0,056
  23. Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV. AIDS. 2022 May 01; 36(6):763-772.
    View in: PubMed
    Score: 0,055
  24. Predictors of Transition to Frailty in Middle-Aged and Older People With HIV: A Prospective Cohort Study. J Acquir Immune Defic Syndr. 2021 12 15; 88(5):518-527.
    View in: PubMed
    Score: 0,055
  25. Multimorbidity networks associated with frailty among middle-aged and older people with HIV. AIDS. 2021 12 01; 35(15):2451-2461.
    View in: PubMed
    Score: 0,055
  26. Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. Clin Infect Dis. 2021 10 05; 73(7):1149-1156.
    View in: PubMed
    Score: 0,054
  27. The Etiology of Pneumonia in HIV-uninfected South African Children: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 09 01; 40(9S):S59-S68.
    View in: PubMed
    Score: 0,054
  28. Low CD4+ cell count nadir exacerbates the impacts of APOE e4 on functional connectivity and memory in adults with HIV. AIDS. 2021 04 01; 35(5):727-736.
    View in: PubMed
    Score: 0,053
  29. Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders. AIDS. 2021 01 01; 35(1):15-22.
    View in: PubMed
    Score: 0,052
  30. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 11 01; 34(13):1907-1914.
    View in: PubMed
    Score: 0,051
  31. Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances. J Neurovirol. 2020 12; 26(6):888-898.
    View in: PubMed
    Score: 0,050
  32. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020 06 11; 17(1):41.
    View in: PubMed
    Score: 0,050
  33. Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study. PLoS One. 2020; 15(6):e0233217.
    View in: PubMed
    Score: 0,050
  34. Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV. J Assoc Nurses AIDS Care. 2020 May-Jun; 31(3):290-300.
    View in: PubMed
    Score: 0,049
  35. Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 03 01; 83(3):251-259.
    View in: PubMed
    Score: 0,049
  36. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 12 01; 33(15):2309-2316.
    View in: PubMed
    Score: 0,048
  37. Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners. Medicine (Baltimore). 2019 Dec; 98(50):e18232.
    View in: PubMed
    Score: 0,048
  38. Risk of developing cerebral ß-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019 11 15; 33(14):2157-2166.
    View in: PubMed
    Score: 0,048
  39. Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy. Curr Med Res Opin. 2019 11; 35(11):1955-1963.
    View in: PubMed
    Score: 0,047
  40. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting. Paediatr Int Child Health. 2020 02; 40(1):50-57.
    View in: PubMed
    Score: 0,046
  41. Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2019 06 01; 81(2):166-174.
    View in: PubMed
    Score: 0,046
  42. Metabolic Syndrome and Neurocognitive Deficits in HIV Infection. J Acquir Immune Defic Syndr. 2019 05 01; 81(1):95-101.
    View in: PubMed
    Score: 0,046
  43. Evidence-informed practical recommendations for increasing physical activity among persons living with HIV. AIDS. 2019 05 01; 33(6):931-939.
    View in: PubMed
    Score: 0,046
  44. Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors. J Affect Disord. 2019 05 15; 251:1-7.
    View in: PubMed
    Score: 0,046
  45. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease. J Neurovirol. 2019 10; 25(5):661-672.
    View in: PubMed
    Score: 0,045
  46. Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):e9-e13.
    View in: PubMed
    Score: 0,045
  47. Sex differences in HIV-associated cognitive impairment. AIDS. 2018 11 28; 32(18):2719-2726.
    View in: PubMed
    Score: 0,045
  48. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 09 10; 32(14):2005-2015.
    View in: PubMed
    Score: 0,044
  49. Impact of time perspectives on texting intervention to reduce HIV/STI transmission among female sex workers in Tijuana and Ciudad Juarez, Mexico. J Behav Med. 2019 02; 42(1):111-127.
    View in: PubMed
    Score: 0,044
  50. Neurocognitive functioning predicts frailty index in HIV. Neurology. 2018 07 10; 91(2):e162-e170.
    View in: PubMed
    Score: 0,043
  51. Patient Responses on Quality of Care and Satisfaction with Staff After Integrated HIV Care in South African Primary Health Care Clinics. J Assoc Nurses AIDS Care. 2018 Sep - Oct; 29(5):698-711.
    View in: PubMed
    Score: 0,043
  52. A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults. AIDS Behav. 2018 May; 22(5):1562-1572.
    View in: PubMed
    Score: 0,043
  53. Integrated HIV-Care Into Primary Health Care Clinics and the Influence on Diabetes and Hypertension Care: An Interrupted Time Series Analysis in Free State, South Africa Over 4 Years. J Acquir Immune Defic Syndr. 2018 04 15; 77(5):476-483.
    View in: PubMed
    Score: 0,043
  54. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 04 24; 31(7):973-979.
    View in: PubMed
    Score: 0,040
  55. Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder. AIDS Res Hum Retroviruses. 2017 Oct; 33(10):1048-1055.
    View in: PubMed
    Score: 0,040
  56. Sexual HIV risk among gay, bisexual and queer transgender men: findings from interviews in Vancouver, Canada. Cult Health Sex. 2017 Nov; 19(11):1197-1209.
    View in: PubMed
    Score: 0,040
  57. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2017 03 27; 31(6):787-795.
    View in: PubMed
    Score: 0,040
  58. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis. 2017 02 27; 17(1):174.
    View in: PubMed
    Score: 0,040
  59. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141.
    View in: PubMed
    Score: 0,039
  60. Can research at the end of life be a useful tool to advance HIV cure? AIDS. 2017 01 02; 31(1):1-4.
    View in: PubMed
    Score: 0,039
  61. Feasibility and Acceptability of Ecological Momentary Assessment of Daily Functioning Among Older Adults with HIV. Am J Geriatr Psychiatry. 2017 Aug; 25(8):829-840.
    View in: PubMed
    Score: 0,039
  62. 'People say that we are already dead much as we can still walk': a qualitative investigation of community and couples' understanding of HIV serodiscordance in rural Uganda. BMC Infect Dis. 2016 11 10; 16(1):665.
    View in: PubMed
    Score: 0,039
  63. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep. 2016 09 06; 6:32947.
    View in: PubMed
    Score: 0,038
  64. Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS. 2016 Mar 27; 30(6):839-48.
    View in: PubMed
    Score: 0,037
  65. Efavirenz as a cause of ataxia in children. S Afr Med J. 2015 Nov; 105(11):897-8.
    View in: PubMed
    Score: 0,036
  66. Integrated Source Case Investigation for Tuberculosis (TB) and HIV in the Caregivers and Household Contacts of Hospitalised Young Children Diagnosed with TB in South Africa: An Observational Study. PLoS One. 2015; 10(9):e0137518.
    View in: PubMed
    Score: 0,036
  67. Gay and bisexual men's awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada. J Int AIDS Soc. 2015; 18:20039.
    View in: PubMed
    Score: 0,036
  68. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 Jul 31; 29(12):1483-91.
    View in: PubMed
    Score: 0,035
  69. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014; 26(12):1477-81.
    View in: PubMed
    Score: 0,033
  70. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,033
  71. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 Jun 01; 28(9):1297-306.
    View in: PubMed
    Score: 0,033
  72. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis. 2014 Jul 15; 59(2):287-97.
    View in: PubMed
    Score: 0,032
  73. Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. Int J Epidemiol. 2015 Feb; 44(1):58-67.
    View in: PubMed
    Score: 0,032
  74. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One. 2014; 9(2):e87872.
    View in: PubMed
    Score: 0,032
  75. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol. 2013 Dec; 19(6):565-73.
    View in: PubMed
    Score: 0,032
  76. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J. 2013 Sep; 32(9):972-7.
    View in: PubMed
    Score: 0,031
  77. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. 2013 Oct; 19(5):410-7.
    View in: PubMed
    Score: 0,031
  78. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013 Jul-Aug; 7(4):255-63.
    View in: PubMed
    Score: 0,031
  79. The resurgence of tuberculosis and the implications for primary care. Br J Gen Pract. 2013 Jul; 63(612):344-5.
    View in: PubMed
    Score: 0,031
  80. A case-controlled study of successful aging in older HIV-infected adults. J Clin Psychiatry. 2013 May; 74(5):e417-23.
    View in: PubMed
    Score: 0,030
  81. Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35.
    View in: PubMed
    Score: 0,029
  82. HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol. 2012; 34(7):773-81.
    View in: PubMed
    Score: 0,028
  83. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012 May; 54(10):1485-94.
    View in: PubMed
    Score: 0,028
  84. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/µL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012 Apr; 54(8):1204-11.
    View in: PubMed
    Score: 0,028
  85. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884.
    View in: PubMed
    Score: 0,027
  86. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS. 2011 Jun 19; 25(10):1317-27.
    View in: PubMed
    Score: 0,027
  87. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2011 Feb 20; 25(4):453-62.
    View in: PubMed
    Score: 0,026
  88. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):451-9.
    View in: PubMed
    Score: 0,026
  89. Successful cognitive aging in persons living with HIV infection. J Neurovirol. 2011 Feb; 17(1):110-9.
    View in: PubMed
    Score: 0,026
  90. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):28-35.
    View in: PubMed
    Score: 0,024
  91. Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda. J Int Assoc Physicians AIDS Care (Chic). 2009 Mar-Apr; 8(2):128-38.
    View in: PubMed
    Score: 0,023
  92. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One. 2009; 4(1):e4149.
    View in: PubMed
    Score: 0,023
  93. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav. 2010 Aug; 14(4):816-23.
    View in: PubMed
    Score: 0,022
  94. Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS. 2008 Oct; 22(10):787-95.
    View in: PubMed
    Score: 0,022
  95. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008 Mar 01; 371(9614):752-9.
    View in: PubMed
    Score: 0,021
  96. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007 Mar 30; 21(6):685-92.
    View in: PubMed
    Score: 0,020
  97. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS. 2006 May 12; 20(8):1117-23.
    View in: PubMed
    Score: 0,019
  98. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS. 2005 Mar 04; 19(4):407-11.
    View in: PubMed
    Score: 0,017
  99. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31.
    View in: PubMed
    Score: 0,016
  100. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12.
    View in: PubMed
    Score: 0,016
  101. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions. Vaccine. 2017 08 03; 35(34):4321-4329.
    View in: PubMed
    Score: 0,010
  102. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,010
  103. Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South Africa. Pediatr Infect Dis J. 2016 Nov; 35(11):1169-1174.
    View in: PubMed
    Score: 0,010
  104. Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2016 Apr 15; 71(5):551-7.
    View in: PubMed
    Score: 0,009
  105. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,009
  106. Temporal association in hospitalizations for tuberculosis, invasive pneumococcal disease and influenza virus illness in South African children. PLoS One. 2014; 9(3):e91464.
    View in: PubMed
    Score: 0,008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.